RS54595B1 - 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives - Google Patents

2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives

Info

Publication number
RS54595B1
RS54595B1 RS20160156A RSP20160156A RS54595B1 RS 54595 B1 RS54595 B1 RS 54595B1 RS 20160156 A RS20160156 A RS 20160156A RS P20160156 A RSP20160156 A RS P20160156A RS 54595 B1 RS54595 B1 RS 54595B1
Authority
RS
Serbia
Prior art keywords
oxo
alkyl containing
imidazothiadiazole derivatives
halogen
pyrrolidinyl
Prior art date
Application number
RS20160156A
Other languages
English (en)
Serbian (sr)
Inventor
Yannick Quesnel
Laurent Turet
Joël MERCIER
Original Assignee
Ucb Biopharma Sprl.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42034570&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS54595(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Biopharma Sprl. filed Critical Ucb Biopharma Sprl.
Publication of RS54595B1 publication Critical patent/RS54595B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433Thidiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
RS20160156A 2009-10-23 2010-10-21 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives RS54595B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09173912 2009-10-23
PCT/EP2010/006434 WO2011047860A1 (en) 2009-10-23 2010-10-21 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives

Publications (1)

Publication Number Publication Date
RS54595B1 true RS54595B1 (en) 2016-08-31

Family

ID=42034570

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20160156A RS54595B1 (en) 2009-10-23 2010-10-21 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives

Country Status (30)

Country Link
US (1) US8822508B2 (forum.php)
EP (1) EP2491045B1 (forum.php)
JP (1) JP5808020B2 (forum.php)
KR (1) KR20120102058A (forum.php)
CN (1) CN102574869A (forum.php)
AR (1) AR078722A1 (forum.php)
AU (1) AU2010310100B2 (forum.php)
BR (1) BR112012009310B8 (forum.php)
CA (1) CA2778194C (forum.php)
CL (1) CL2012001031A1 (forum.php)
CY (1) CY1117288T1 (forum.php)
DK (1) DK2491045T3 (forum.php)
EA (1) EA201200616A1 (forum.php)
ES (1) ES2565515T3 (forum.php)
HR (1) HRP20160263T1 (forum.php)
HU (1) HUE028668T2 (forum.php)
IL (1) IL218696A0 (forum.php)
IN (1) IN2012DN02793A (forum.php)
MA (1) MA33679B1 (forum.php)
ME (1) ME02355B (forum.php)
MX (1) MX347070B (forum.php)
PE (1) PE20121562A1 (forum.php)
PH (1) PH12012500570A1 (forum.php)
PL (1) PL2491045T3 (forum.php)
RS (1) RS54595B1 (forum.php)
SI (1) SI2491045T1 (forum.php)
SM (1) SMT201600076B (forum.php)
TN (1) TN2012000147A1 (forum.php)
TW (1) TW201118103A (forum.php)
WO (1) WO2011047860A1 (forum.php)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8957218B2 (en) * 2011-04-18 2015-02-17 Ucb Pharma S.A. 2-oxo-1-imidazolidinyl imidazothiadiazole derivatives
US9581654B2 (en) 2013-02-12 2017-02-28 Johnson Controls Technology Company Vehicle battery monitoring system
PT3096790T (pt) 2014-01-21 2019-10-15 Janssen Pharmaceutica Nv Combinações compreendendo moduladores alostéricos positivos ou agonistas ortostéricos do recetor glutamatérgico metabotrópico do subtipo 2 e seu uso
EP3827830A1 (en) 2014-01-21 2021-06-02 Janssen Pharmaceutica NV Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
CN110869374B (zh) * 2017-07-10 2022-08-30 Ucb生物制药有限责任公司 2-氧代-1,3-噁唑烷基咪唑并噻二唑衍生物
MA49558A (fr) 2017-07-10 2021-05-05 UCB Biopharma SRL Dérivativés de 2-oxo-1-imidazolidinyl imidazothiadiazole
CN107827870B (zh) * 2017-10-24 2019-11-08 江苏仁明生物科技有限公司 一种正电子药物[18f]fpmmp及其制备方法与中间体
EA202091403A1 (ru) * 2017-12-12 2020-10-14 Юсб Байофарма Срл Производные 2-оксо-1-пирролидинилимидазотиадиазола
US11286266B2 (en) 2018-05-08 2022-03-29 UCB Biopharma SRL 1-imidazothiadiazolo-2H-pyrrol-5-one derivatives
CN113549052B (zh) * 2021-07-09 2022-09-02 首都医科大学脑重大疾病研究中心(北京脑重大疾病研究院) 4-苯基-1-(吡啶-4-基甲基)吡咯烷-2-酮衍生物及其制备方法和应用
WO2025132331A1 (en) 2023-12-21 2025-06-26 UCB Biopharma SRL Compounds for treatment of a hyperkinetic movement disorder
CN119606962B (zh) * 2025-02-17 2025-05-02 中国人民解放军总医院第三医学中心 padsevonil在制备治疗TFE3重排性肾细胞癌的药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412358D0 (en) 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition
GB8412357D0 (en) 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition
GB0004297D0 (en) 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
ES2323313T3 (es) 2003-12-02 2009-07-13 Ucb Pharma, S.A. Derivados de imidazol, procedimientos para prepararlos y sus usos.
EP2308867A3 (en) * 2005-06-01 2011-10-19 UCB Pharma S.A. 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses

Also Published As

Publication number Publication date
EA201200616A1 (ru) 2012-12-28
HRP20160263T1 (hr) 2016-04-08
BR112012009310B8 (pt) 2021-05-25
BR112012009310A2 (pt) 2016-06-07
ME02355B (me) 2016-06-20
MA33679B1 (fr) 2012-10-01
AU2010310100B2 (en) 2015-09-10
AU2010310100A1 (en) 2012-05-17
IL218696A0 (en) 2012-05-31
CA2778194A1 (en) 2011-04-28
DK2491045T3 (en) 2016-03-14
ES2565515T3 (es) 2016-04-05
CA2778194C (en) 2016-07-12
US20120245208A1 (en) 2012-09-27
CY1117288T1 (el) 2017-04-26
US8822508B2 (en) 2014-09-02
TN2012000147A1 (en) 2013-09-19
JP5808020B2 (ja) 2015-11-10
EP2491045B1 (en) 2015-12-23
AR078722A1 (es) 2011-11-30
MX347070B (es) 2017-04-11
SMT201600076B (it) 2016-04-29
PH12012500570A1 (en) 2012-10-22
EP2491045A1 (en) 2012-08-29
TW201118103A (en) 2011-06-01
MX2012003839A (es) 2012-05-08
PL2491045T3 (pl) 2016-06-30
CL2012001031A1 (es) 2012-09-14
HUE028668T2 (en) 2016-12-28
JP2013508321A (ja) 2013-03-07
CN102574869A (zh) 2012-07-11
BR112012009310B1 (pt) 2021-01-12
SI2491045T1 (sl) 2016-04-29
KR20120102058A (ko) 2012-09-17
PE20121562A1 (es) 2012-11-30
WO2011047860A1 (en) 2011-04-28
IN2012DN02793A (forum.php) 2015-07-24

Similar Documents

Publication Publication Date Title
RS54595B1 (en) 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives
MX2021013075A (es) Oxisteroles y metodos de uso de los mismos.
RS52261B (en) AMIDOPHENOX INDASOLS AS A USEFUL C-MET INHIBITOR
RS52870B (en) INHIBITOR PROLIL HYDROXYLASE
RS54526B1 (en) USE OF PIRAZOLOSPIROKETONE DERIVATIVES AS ACETYL-COA CARBOXYLASE INHIBITORS
NO20080865L (no) Spirokromanonderivater som acetyl-koenzym-A-karboksylase(ACC)inhibitorer
AR082826A2 (es) Inhibidores heterociclicos de mek, composiciones farmaceuticas que los contienen, usos, y metodos de preparacion de los mismos
RS52534B (en) MACROCYCLIC COMPOUNDS OF HINOXALINE AS HCV NS3 PROTEASE INHIBITORS
RS54260B1 (en) AMINODIHYDROTIAZINE DERIVATIVES AS BACE INHIBITORS FOR ALZHEIMER DISEASE TREATMENT
CR11518A (es) Compuestos de carbamoilo como inhibidores de dgat1 190
NO20091553L (no) Fenylderivater og deres anvendelse som immunmodulatorer
NO20073791L (no) Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer
NO20081724L (no) Stabil farmasoytisk sammensetning omfattende et pyrimidin-sulfamid
UY30897A1 (es) Derivados de pentafluorotiobenzamidoacetonitrilo, composiciones conteniéndolos y aplicaciones
CL2012000999A1 (es) Compuestos derivados de pirazoloespirocetona sustituida, inhibidores de acetil-coa carboxilasa; composicion farmaceutica que los comprende; uso para tratar o retrasar la progresion o el inicio de diabetes tipo 2, higado graso no alcoholico (hgna) o la resistencia hepatica a la insulina.
MA37142A3 (fr) Dérivés de dihydro-benzo-oxazine et de dihydro-pyrido-oxazine
AR062211A1 (es) Derivados de 6-carboxi-normorfinano. composiciones farmaceuticas
WO2008036652A3 (en) Amidines as modulators of indoleamine 2,3-dioxygenase
GT200600134A (es) Compuestos novedosos de derivados de aminosulfonilo
RS54730B1 (sr) Inhibitori beta sekretaze
EA200900924A1 (ru) Циклизованные производные как ингибиторы eg-5
AR054341A1 (es) Combinaciones sinergicas de compuestos activos fungicidas
EA200900631A1 (ru) Замещённые пиразолы и триазолы, как ингибиторы кбв (кинезин-белок веретена)
EA200801366A1 (ru) Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина
UY30787A1 (es) "inhibidores benzoimidazolicos de trpv1"